Dade Behring公司资助的C反应蛋白网址闪亮登场

互联网上一个新的网址(www.crphealth.com)被设计用于作为医学专业人员与他们患者的C反应蛋白数据的最新更新。

这个网址每日升级，内容包括使用高密度C反应蛋白做为心血管疾病与中风的预后指标，以及做为观察性研究与临床试验的结果。评审内容的专家委员会包括Paul Ridker医生(哈佛波士顿医学院医学教授，MA, USA)、Nader Rifai医生(哈佛医学院副教授)和Wolfgang Koenig医生(德国乌尔姆大学医学中心的医学/心血管科教授)。该网址的赞助者之一是美国Dade Behring公司(Deerfield, IL, USA)。

该网址的内容包括专家对炎症与心脏疾病的交互式论坛、多媒体展示、病例研究、讨论论坛、自我评估、幻灯和录像图书馆、治疗大纲、参考文献、调查、以及最新的有关C反应蛋白的医学论文以及经常被问及的问题。

Dade Behring公司主席、总裁兼首席执行官Jim Reid-Anderson评论说：“这个新网址是我们公司坚持不懈努力的一个明证：即为医疗保健提供者与患者提供信息以满足他们的需要，从而获得最佳质量的健康保健”
 
New Website on C-Reactive Protein
 
A new website on the Internet (www.crphealth.com) is designed as a source for the latest updates on C-reactive protein (CRP) for medical professionals and their patients.

The website is updated daily and includes content on the use of high-density CRP (hsCRP) as a prognostic indicator of cardiovascular disease and stroke, as well as the results of observational studies and clinical trials. The editorial board of specialists reviewing the content includes Dr. Paul Ridker (professor of medicine, Harvard Medical School in Boston, MA, USA), Dr. Nader Rifai (associate professor, Harvard Medical School), and Dr. Wolfgang Koenig (professor of medicine/cardiology, University of Ulm Medical Center, in Germany). A sponsor of the website is Dade Behring (Deerfield, IL, USA).

The website’s content includes interactive forums, multimedia presentations by experts on inflammation and heart disease, case studies, discussion forums, self-assessments, slide and video libraries, treatment guidelines, references, polls, and the latest medical publications on CRP, as well as frequently asked questions.

“This new website exemplifies our company’s continuous efforts to make information available to healthcare providers and patients that meets their needs and enables the best quality of care,” remarked Jim Reid-Anderson, chairman, president, and CEO of Dade Behring.